Suchergebnisse - "Drug development and approval"

PubPharm (23)

1

Voclosporin : A Novel Calcineurin Inhibitor for the Treatment of Lupus Nephritis

enthalten in: The Annals of pharmacotherapy | 2022

von McArn, A. | Nixon, A. | Jarrell, K.

2

Amisulpride : A New Drug for Management of Postoperative Nausea and Vomiting

enthalten in: The Annals of pharmacotherapy | 2021

von Haber, S. | Graybill, A. | Minasian, A.

3

Osilodrostat : A Novel Steroidogenesis Inhibitor to Treat Cushing's Disease

enthalten in: The Annals of pharmacotherapy | 2021

von Dougherty, J. | Desai, D. | Herrera, J.

4

Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2021

von Hvisdas, C.

5

Doing More With Less : Review of Dolutegravir-Lamivudine, a Novel Single-Tablet Regimen for Antiretroviral-Naïve Adults With HIV-1 Infection

enthalten in: The Annals of pharmacotherapy | 2020

von Santevecchi, B. | Miller, S. | Childs-Kean, L.

6

Apalutamide : A new agent in the management of prostate cancer

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2019

von May, M. | Glode, A.

7

Baricitinib : The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis

enthalten in: The Annals of pharmacotherapy | 2019

von Mogul, A. | Corsi, K. | McAuliffe, L.

8

Glycopyrrolate/eFlow CS : The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease

enthalten in: The Annals of pharmacotherapy | 2019

von Pleasants, R.

9

Lifitegrast : a novel drug for patients with dry eye disease

enthalten in: Therapeutic advances in ophthalmology | 2019

von Haber, S. | Benson, V. | Buckway, C. | +3

10

Exploratory analysis of comparative clinical trials used for marketing approval in patients with type 2 diabetes in Japan

enthalten in: SAGE open medicine | 2019

von Kaneko, R. | Ono, S.